Kimberly K. Ryan - 31 Dec 2025 Form 4 Insider Report for Hillenbrand, Inc. (HI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 16:20:00 UTC
Prior SEC filing
09 Dec 2025
Next SEC filing
10 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Allison A. Westfall, Attorney-in-Fact for Kimberly K. Ryan

Key filing fact

Kimberly K. Ryan filed Form 4 for Hillenbrand, Inc. (HI) on 05 Jan 2026.

Key facts

  • This page summarizes Kimberly K. Ryan's Form 4 filing for Hillenbrand, Inc. (HI).
  • 4 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 05 Jan 2026, 16:20.

Change

  • Previous filing in this sequence was filed on 09 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001256332 Primary reporting owner

RYAN KIMBERLY K

Relationship
President & CEO
Address
ONE BATESVILLE BOULEVARD, BATESVILLE
Signature
/s/ Allison A. Westfall, Attorney-in-Fact for Kimberly K. Ryan
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
208,946
Date
31 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/7/2023)

Award

Transaction value
$0
Shares
+103
Change %
+0.72%
Price
$0.000000
Shares after
14,491
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
103
Exercise price
Footnotes
F1, F2, F3
HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/5/2024)

Award

Transaction value
$0
Shares
+250
Change %
+0.72%
Price
$0.000000
Shares after
35,198
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250
Exercise price
Footnotes
F1, F2, F4
HI transaction Derivative

Restricted Stock Units (Matching RSU Framework 03/31/2025)

Award

Transaction value
$0
Shares
+271
Change %
+0.72%
Price
$0.000000
Shares after
38,100
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
271
Exercise price
Footnotes
F1, F2, F5
HI transaction Derivative

Restricted Stock Units (Deferred Stock Award 12/4/2025)

Award

Transaction value
$0
Shares
+1,308
Change %
+0.72%
Price
$0.000000
Shares after
183,697
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,308
Exercise price
Footnotes
F1, F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

Footnote F2

Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

Footnote F3

Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

Footnote F4

Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

Footnote F5

Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

Footnote F6

Restricted Stock Units scheduled to vest one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .